EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Photodynamic Priming and Minocycline Overcome Chemoresistance by Reprogramming the Pancreatic Tumor Immune Microenvironment In Vivo

Fernanda V Cabral iD, Jose Quilez-Alburquerque, Olivia Mooradian, Shivendran Vytheswarran, Badri Parshad, Girgis Obaid iD, Huang-Chiao Huang iD, Tayyaba Hasan iD

Advanced Science · 2026-07 · 13 (38)

DOI: 10.1002/advs.75291 ↗

At a glance

Journal article in Advanced Science, published online on 2026-04-17. Written by Fernanda V Cabral and 7 co-authors. Institution: Wellman Center For Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. Major MEDLINE topics: Tumor Microenvironment, Pancreatic Neoplasms, Minocycline, Drug Resistance, Neoplasm. Cited 1 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIBIB NIH HHS, NIH HHS, NCI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Overcoming drug resistance in pancreatic ductal adenocarcinoma (PDAC) remains a major challenge due to dense fibrotic stroma, DNA repair–mediated resistance, drug efflux mechanisms, and an immunosuppressive tumor microenvironment (TME). Here, we use photoactivatable multi‐inhibitor liposomes (PMILs) as a clinically translatable strategy to immunomodulate and enhance PDAC treatment using FDA‐approved agents: minocycline for tumor priming by downregulating Tdp1, benzoporphyrin derivative incorporated into the liposomal bilayer for photodynamic priming (PDP) of the microenvironment, and irinotecan (IRI) for cytotoxicity. PMILs enable light‐triggered PDP followed by IRI release. The reduced Tdp1 combined with PDP and IRI acts synergistically to enhance antitumor activity. In an orthotopic PDAC mouse model, dual priming significantly increased intratumoral IRI accumulation while downregulating Tdp1 and ABCG2, two key mediators of IRI resistance. These effects were augmented by immune activation, including increased CD8 + T‐cell infiltration, reduced regulatory T cells, and M2‐like macrophage population. This combination achieved sustained local tumor regression, abscopal effects in untreated distant tumors, and a significant improvement in long‐term survival (63%). By integrating clinically approved agents with non‐overlapping mechanisms within a light‐activated delivery platform, this approach enhances IRI efficacy, reprograms the TME, and promotes antitumor immunity, offering a translatable strategy to sensitize PDAC to chemo‐ and immunotherapy.

Subjects

MeSH terms (MEDLINE)

Tumor MicroenvironmentPancreatic NeoplasmsMinocyclineDrug Resistance, NeoplasmPhotochemotherapyCarcinoma, Pancreatic DuctalAnimalsMiceHumansCell Line, TumorIrinotecanDisease Models, Animal

Author keywords

antitumor immune activationminocycline primingpancreatic cancerphotodynamic primingtumor microenvironment remodeling

Substances

MinocyclineIrinotecan

Authors and institutions

  • Wellman Center For Photomedicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Bioengineering, University of Texas at Dallas, Richardson, Texas, USA.
  • Fischell Department of Bioengineering, College Park, University of Maryland, Maryland, MD, USA.
  • Division of Health Sciences and Technology, Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.

ORCID profiles: Fernanda V Cabral, Girgis Obaid, Huang-Chiao Huang, Tayyaba Hasan

Funding

  • NIBIB NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • National Science Foundation

Cite

APA

Cabral, F. V., Quilez-Alburquerque, J., Mooradian, O., Vytheswarran, S., Parshad, B., Obaid, G., Huang, H. C., & Hasan, T. (2026). Photodynamic Priming and Minocycline Overcome Chemoresistance by Reprogramming the Pancreatic Tumor Immune Microenvironment In Vivo. Advanced Science, 13(38). https://doi.org/10.1002/advs.75291

Vancouver

Cabral FV, Quilez-Alburquerque J, Mooradian O, Vytheswarran S, Parshad B, Obaid G, et al. Photodynamic Priming and Minocycline Overcome Chemoresistance by Reprogramming the Pancreatic Tumor Immune Microenvironment In Vivo. Advanced Science. 2026;13(38). doi:10.1002/advs.75291

BibTeX
@article{Cabral2026,
  author = {Cabral, Fernanda V and Quilez-Alburquerque, Jose and Mooradian, Olivia and Vytheswarran, Shivendran and Parshad, Badri and Obaid, Girgis and Huang, Huang-Chiao and Hasan, Tayyaba},
  title = {Photodynamic Priming and Minocycline Overcome Chemoresistance by Reprogramming the Pancreatic Tumor Immune Microenvironment In Vivo},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {38},
  doi = {10.1002/advs.75291}
}
Start for free →